Nuvalent | Investor Presentation Deck | 39 slides · page 28 of 39
The table highlights the progression of resistance mutations and the increasing prevalence of CNS disease as patients move through lines of therapy.
Pitch deck · market_sizing · size_opportunity · balanced density
Slide locked Sign in to view
Slide schematic 4/4
source-note 1/1 table 1/1 title 2/2
Components 4
source-note data action-title headline
Tools 0
∅
No tools
No canon tool match is anchored to this slide.
Metrics 0
∅
No metrics
No metric insight is anchored to this slide.
Frameworks 1